1. Characterizing the molecular features of ERG‐positive tumors in primary and castration resistant prostate cancer. Issue 9 (16th March 2016) Authors: Roudier, Martine P.; Winters, Brian R.; Coleman, Ilsa; Lam, Hung‐Ming; Zhang, Xiaotun; Coleman, Roger; Chéry, Lisly; True, Lawrence D.; Higano, Celestia S.; Montgomery, Bruce; Lange, Paul H.; Snyder, Linda A.; Srivastava, Shiv; Corey, Eva; Vessella, Robert L.; Nelson, Peter S.; Üren, Aykut; Morri... Journal: Prostate Issue: Volume 76:Issue 9(2016) Page Start: 810 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer. Issue 1 (December 2018) Authors: Jansson, Keith; Tucker, John; Stahl, Lauren; Simmons, John; Fuller, Caitlyn; Beshiri, Michael; Agarwal, Supreet; Fang, Lei; Hynes, Paul; Alilin, Aian; Lake, Ross; Abbey, Yasmine; Cawley, Jacob; Tice, Caitlin; Yin, JuanJuan; McKnight, Crystal; Klummp-Thomas, Carleen; Zhang, Xiaohu; Guha, Rajarshi;... Journal: Scientific reports Issue: Volume 8:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. (December 2018) Authors: Rotinen, Mirja; You, Sungyong; Yang, Julie; Coetzee, Simon; Reis-Sobreiro, Mariana; Huang, Wen-Chin; Huang, Fangjin; Pan, Xinlei; Yáñez, Alberto; Hazelett, Dennis; Chu, Chia-Yi; Steadman, Kenneth; Morrissey, Colm; Nelson, Peter; Corey, Eva; Chung, Leland; Freedland, Stephen; Vizio, Dolores; Garra... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1887 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics. Issue 6 (3rd February 2017) Authors: Nguyen, Holly M.; Vessella, Robert L.; Morrissey, Colm; Brown, Lisha G.; Coleman, Ilsa M.; Higano, Celestia S.; Mostaghel, Elahe A.; Zhang, Xiaotun; True, Lawrence D.; Lam, Hung‐Ming; Roudier, Martine; Lange, Paul H.; Nelson, Peter S.; Corey, Eva Journal: Prostate Issue: Volume 77:Issue 6(2017) Page Start: 654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer. Issue 4 (23rd September 2021) Authors: Asrani, Kaushal; Torres, Alba FC; Woo, Juhyung; Vidotto, Thiago; Tsai, Harrison K; Luo, Jun; Corey, Eva; Hanratty, Brian; Coleman, Ilsa; Yegnasubramanian, Srinivasan; De Marzo, Angelo M; Nelson, Peter S; Haffner, Michael C; Lotan, Tamara L Journal: Journal of pathology Issue: Volume 255:Issue 4(2021) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained Slides. Issue 5 (9th October 2017) Authors: Baena-Del Valle, Javier A; Zheng, Qizhi; Hicks, Jessica L; Fedor, Helen; Trock, Bruce J; Morrissey, Colm; Corey, Eva; Cornish, Toby C; Sfanos, Karen S; De Marzo, Angelo M Journal: American journal of clinical pathology Issue: Volume 148:Issue 5(2017) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Magneto‐Endosomalytic Therapy for Cancer. Issue 9 (6th August 2021) Authors: Zhao, Pengfei; Han, Yan; Nguyen, Holly; Corey, Eva; Gao, Xiaohu Other Names: Xia Younan guestEditor. Journal: Advanced healthcare materials Issue: Volume 11:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells. Issue 1 (31st December 2022) Authors: Krishn, Shiv Ram; Garcia, Vaughn; Naranjo, Nicole M.; Quaglia, Fabio; Shields, Christopher D.; Harris, Maisha A.; Kossenkov, Andrew V.; Liu, Qin; Corey, Eva; Altieri, Dario C.; Languino, Lucia R. Journal: Cancer biology & therapy Issue: Volume 23:Issue 1(2022) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MP06-05 UROTHELIAL CANCER RAPID AUTOPSY PROGRAM: BIOSPECIMENS AND PATIENT-DERIVED PRECLINICAL MODELS. (May 2022) Authors: Garcia, Jose; Vakar-Lopez, Funda; Roudier, Martine; Grivas, Petros; Yu, Evan Y.; Cheng, Heather; Schweizer, Michael T.; Haffner, Michael; Lee, John K.; Corey, Eva; Montgomery, Bruce; Hsieh, Andrew; Wright, Jonathan L.; Lam, Hung-Ming Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy. (28th April 2021) Authors: Ma, Tianfang; Bai, Shanshan; Qi, Yanfeng; Zhan, Yang; Ungerleider, Nathan; Zhang, Derek Y.; Neklesa, Taavi; Corey, Eva; Dehm, Scott M.; Zhang, Kun; Flemington, Erik K.; Dong, Yan Journal: Cancer letters Issue: Volume 504(2021) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗